Neonatal Omphalitis (Umbilical Cord Infection)

Overview

Omphalitis is a bacterial infection of the newborn's umbilical cord stump and surrounding tissue, usually appearing within the first days of life, on average on day 3; if untreated, it can rapidly progress to sepsis, necrotizing fasciitis, or death. According to the StatPearls review, its incidence in developed countries is approximately 0.7%, while in developing countries it rises to 8% for hospital births and up to 22% for home births; this difference largely depends on whether the cord was cut under sterile conditions and the conditions of postnatal care.

Pathophysiologically, the devitalized tissue in the umbilical stump provides a suitable environment for bacterial colonization; thrombotic vessels in the stump lay the groundwork for the infection to directly enter the bloodstream and thus spread systemically. The infection is typically polymicrobial and consists of a mix of skin flora and enteric bacteria; the most frequently isolated agents are Staphylococcus aureus (including MRSA), group A streptococcus, gram-negative bacilli such as E. coli, and anaerobic bacteria (Bacteroides, Clostridium).

The clinical picture can range widely, starting from limited periumbilical erythema and serous discharge to spreading cellulitis, purulent discharge, fetid odor, induration, and systemic toxicity; the community-based study by Mullany and colleagues has shown that looking for redness extending to the base of the umbilicus along with the presence of pus distinguishes moderate and severe cases with high specificity and moderate-to-high sensitivity; therefore, in practice, the combination of 'extent of redness + purulent discharge' is the most reliable clinical point of distinction. Diagnosis is made by clinical examination; laboratory tests include complete blood count, culture from discharge, and if systemic findings are present, a full sepsis panel (blood culture, urinalysis/culture, cerebrospinal fluid examination if necessary, and chest X-ray) is requested.

The most feared complication is necrotizing fasciitis; rapidly progressing erythema, blister formation, darkening or purple-black discoloration of the skin, crepitus, and a toxic appearance disproportionate to pain suggest this diagnosis and require urgent surgical consultation; additionally, failure to achieve a clinical response to intravenous antibiotics within 24-48 hours is also considered a warning for necrotizing fasciitis. Prematurity, low birth weight, prolonged rupture of membranes, chorioamnionitis, invasive umbilical catheterization, non-sterile delivery and cord care (such as some cultural practices like applying cow dung to the umbilicus), and underlying immunodeficiencies such as leukocyte adhesion defect are listed among risk factors; in a baby with recurrent infections, delayed umbilical cord separation, and a history of omphalitis, leukocyte adhesion defect should be considered.

Key considerations

• Physiological umbilical erythema or drying stump changes remain limited without signs of infection, and are not accompanied by discharge, induration, or systemic findings.
• Umbilical granuloma appears as a pink, moist tissue mass that bleeds easily; serous discharge may be present, but erythema, induration, or systemic signs are absent.
• Umbilical polyp is a hard mass originating from urachal or vitelline remnant tissue and, unlike granulomas, does not shrink with silver nitrate.
• Patent urachus or omphalomesenteric duct remnant causes continuous watery (urine-smelling) or mucous discharge from the umbilicus; the discharge persists even without infection and the canal can be demonstrated by imaging.
• Funisitis is inflammation of the umbilical cord itself due to chorioamnionitis; there is usually no significant erythema or induration on the surrounding skin.
• Necrotizing fasciitis is not merely the most dangerous mimic of omphalitis but rather its directly advanced form, distinguished by rapidly spreading erythema, blister formation, purple-black skin color changes, crepitation, and a toxic appearance disproportionate to the findings; mortality has been reported between 60-85%, and recognition requires surgical decision within minutes.
• Sepsis can originate from another source (respiratory, urinary tract, bloodstream) even without omphalitis findings; especially in premature infants, even if umbilical findings are subtle, if systemic toxicity is present, the sepsis investigation should be expanded (see [[neonatal-sepsis]]).
• Portal vein thrombosis and the resulting cavernous transformation can appear as a rare but late complication of omphalitis; it is not considered in the differential diagnosis in the acute phase but should be kept in mind during follow-up because it initially may be asymptomatic and present months later with signs of portal hypertension.
• Septic umbilical arteritis is a rarer condition where the hardness and tenderness around the umbilicus are limited to the vascular bed, and a high index of suspicion is required for diagnosis.

Why it matters

According to Nelson Textbook of Pediatrics, neonatal omphalitis is defined as polymicrobial infection of the umbilical stump and requires urgent evaluation as it can rapidly progress to necrotizing fasciitis and systemic sepsis. The study by Sawardekar KP (Pediatr Infect Dis J, 2004) showed that the causative agents of omphalitis vary geographically and temporally, with S. aureus (including MRSA) and gram-negative bacilli (especially E. coli) being the most frequently isolated agents; therefore, empirical treatment should cover gram-positive, gram-negative, and anaerobes.

The StatPearls review also recommends an initial empirical regimen consisting of antistaphylococcal penicillin (like ampicillin) combined with an aminoglycoside, adding vancomycin if local MRSA prevalence is high, and adding clindamycin or metronidazole for anaerobic coverage if there is fetid discharge or a history of chorioamnionitis; in uncomplicated cases, parenteral therapy duration is 10 days, followed by oral transition based on culture results — the 7-10 day period in this protocol is consistent with this data. The spread of erythema beyond 0.5-1 cm from the periumbilical area, purulent/foul-smelling discharge, and systemic signs are considered indicators of severe/complicated omphalitis and possible sepsis, and indicate hospitalization with IV antibiotics; this threshold is based on the 'redness spreading to the base of the umbilicus + pus' combination defined in Mullany and colleagues' community-based algorithm study, and this combination captures severe cases with high specificity.

In contrast, isolated mild periumbilical erythema and a small amount of serous discharge can be followed as outpatients with close monitoring when systemic signs are absent. There is significant divergence among guidelines regarding cord care: the Cochrane systematic review (Sinha et al., 2015) and Imdad et al.'s BMC Public Health 2013 meta-analysis showed that cord cleaning with 4% chlorhexidine in home births and communities with high neonatal mortality reduced omphalitis risk by about 27-54% depending on severity and decreased all-cause neonatal mortality by about 23%; the WORLD Health Organization added 7.1% chlorhexidine digluconate to the Essential Medicines List in 2013 based on this evidence.

However, THE SAME body of evidence has shown that in hospital births and in countries with low neonatal mortality (developed countries), chlorhexidine does not show superiority over dry cord care; therefore, the American Academy of Pediatrics continues to recommend dry cord care (clean, wash with water, let dry) instead of routine chlorhexidine in developed settings. In other words, the doctrine 'chlorhexidine for every newborn' is not universal — the recommendation varies according to the hygiene level of the birth setting and neonatal mortality; the phrase 'cleaning with alcohol/antiseptic' in this protocol should be read as compatible with the dry care approach in low-risk settings.

Critical complications

• Sepsis is the most common and significant complication of omphalitis; thrombosed umbilical vessels allow direct entry of infection into the bloodstream, and therefore every newborn with omphalitis must be fully evaluated for sepsis with a low threshold (see [[neonatal-sepsis]]).
• Necrotizing fasciitis is characterized by rapidly spreading erythema, bullae, skin color changes, and crepitus; the reported mortality is between 60-85% and management is not limited to antibiotics, requiring urgent surgical debridement and source control.
• Peritonitis and intestinal gangrene can occur with the progression of the infection from the abdominal wall into the peritoneal cavity; abdominal distension, tenderness, and clinical deterioration are observed, and urgent surgical evaluation is required.
• Small bowel evisceration is a rare but severe outcome of advanced abdominal wall necrosis and requires emergency surgical repair.
• Portal vein thrombosis and associated cavernous transformation is a late complication; months later, it can progress to extrahepatic portal hypertension, which may present with esophageal or gastric varices and upper gastrointestinal bleeding. Therefore, this diagnosis should be considered in a child with a history of omphalitis who presents with unexplained splenomegaly or gastrointestinal bleeding.
• Liver abscess and septic umbilical arteritis are less common but, if recognition is delayed, can persist as a source of sepsis; they should be investigated with imaging (ultrasound).
• Nephrotoxicity and ototoxicity related to aminoglycoside (gentamicin) treatment are iatrogenic complications; incorrect dosing intervals in neonates (not every 8 hours, but extended according to gestational/postnatal age) increase this risk, and therefore drug level monitoring is recommended.
• Rapid infusion of vancomycin can lead to red man syndrome; hence, the infusion time should be at least 60 minutes, which is a rule established to prevent an iatrogenic complication.

Special considerations

• The risk of omphalitis is significantly higher in premature and low birth weight infants compared to term infants; in this group, any sign of omphalitis, even if mild, requires admission and IV treatment at a lower threshold because progression to sepsis can be faster.
• Gentamicin and vancomycin clearance is reduced in premature infants with low gestational and postnatal age; therefore, the dosing interval is extended compared to older children, and doses should not be repeated without drug level monitoring.
• Clindamycin dose in neonates cannot be calculated with a single mg/kg value; different mg/kg multipliers are used according to postmenstrual age bands (under 32 weeks, 32-40 weeks, 40-60 weeks), otherwise a premature infant may receive approximately double the intended dose.
• Omphalitis can recur in infants with underlying primary immunodeficiency, such as leukocyte adhesion defect, and the umbilical cord falls off much later than expected; a history of recurrent or unusually severe omphalitis requires investigation of this diagnosis.
• In babies born at home, under unhygienic birth conditions, or in regions with high infant mortality rates, umbilical cord care with chlorhexidine reduces both omphalitis and all-cause mortality; however, in babies born in hospitals and in settings with advanced healthcare systems, this benefit has not been demonstrated and dry cord care is sufficient.
• In babies who have had umbilical vein catheterization (especially those monitored in intensive care), the risk of omphalitis and portal vein thrombosis is increased; the threshold for evaluating the umbilical area and, if necessary, imaging of the portal system should be lower in these babies.
• In babies born to mothers with a history of chorioamnionitis, differentiating funisitis from omphalitis can be difficult; if the mother’s history is positive, sepsis assessment in the newborn should be extended.

Follow-up plan

In mild cases monitored on an outpatient basis, follow-up examination is recommended within 24-48 hours; this interval has been determined considering the potential of omphalitis to worsen rapidly within hours to days. If erythema spreads, discharge becomes purulent, fever or hypothermia develops, feeding decreases, or lethargy occurs, the family should return immediately, and these warnings should be given orally and in writing at discharge.

For hospitalized cases, the duration of antibiotic therapy and the decision to switch to oral medication are determined by monitoring both clinical response (regression of erythema, reduction of discharge, improvement of systemic signs) and laboratory trends (decreasing CRP and leukocyte counts); if the expected clinical improvement is not observed within 24-48 hours, reevaluation for necrotizing fasciitis and imaging/surgical consultation should be considered. In cases of necrotizing fasciitis, surgical wound care, possible need for repeat debridement, and nutritional support are jointly managed with neonatal intensive care and pediatric surgery follow-up.

In infants who have experienced severe or complicated omphalitis due to the risk of portal vein thrombosis, it is recommended to evaluate the liver and portal system by ultrasound after the acute period and to reconsult for portal hypertension if unexplained splenomegaly, cytopenia, or gastrointestinal bleeding develops in the long term. Upon discharge, the family should be thoroughly informed about umbilical care (dry care or chlorhexidine application depending on the hygiene level of the birth environment) and the warning signs mentioned above.